A Somatotropin-Producing Pituitary Adenoma With an Isolated Adrenocorticotropin-Producing Pituitary Adenoma in a Female Patient With Acromegaly, Subclinical Cushing^|^rsquo;s Disease and a Left Adrenal Tumor

Endocrine Journal - Japan
doi 10.1507/endocrj.ej14-0093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Endocrine Society

Related search

Comment on ^|^ldquo;A Somatotropin-Producing Pituitary Adenoma With an Isolated Adrenocorticotropin-Producing Pituitary Adenoma in a Female Patient With Acromegaly, Subclinical Cushing^|^rsquo;s Disease and a Left Adrenal Tumor^|^rdquo; [Letter to the Editor]

Endocrine Journal
EndocrinologyMetabolismDiabetes
2014English

Bromoderma in a Pituitary Adenoma Patient Treated With Bromocriptine

Journal of Dermatology
DermatologyMedicine
2016English

A Rare Presentation of Adrenal Adenoma in Infancy: Isolated Cushing`s Syndrome

Turkish Journal of Pediatrics
Child HealthPediatricsPerinatology
2020English

Invasive Growth Hormone Producing Pituitary Adenoma With Lymphocytic Infiltration: A Case Report and Literature Review

Iranian Journal of Cancer Prevention
2015English

Electron Microscopic Study of Human Prolactin Producing Pituitary Adenoma

Neurologia Medico-Chirurgica
SurgeryNeurology
1981English

Pituitary Adenoma Occurring With Acromegaly Coexisting With Partially Empty Sella Syndrome

OnCOReview
Oncology
2015English

Aggressive Cushing Disease Five Years After the Treatment of a Nonfunctional Pituitary Adenoma

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2016English

GH-Producing Pituitary Adenoma and Concomitant Rathke’s Cleft Cyst: A Case Report and Short Review

Case Reports in Neurological Medicine
2015English

Ossifying Pituitary Adenoma Co-Existing With Astrocytoma and Gangliocytoma Associated With Pituitary Adenoma. Two Unusual Conditions

Turkish Neurosurgery
SurgeryNeurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy